Get the Stockscreener App
37.07
5.14%
-2.01
Omnicell Inc stock is traded at $37.07, with a volume of 1.60M.
It is down -5.14% in the last 24 hours and down -21.24% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$39.08
Open:
$38.51
24h Volume:
1.60M
Relative Volume:
2.77
Market Cap:
$1.66B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
74.14
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
-23.57%
1M Performance:
-21.24%
6M Performance:
+19.23%
1Y Performance:
-5.99%
1-Day Range:
$36.69
$39.47
1-Week Range:
$36.69
$50.19
52-Week Range:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
37.07 | 1.75B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
183.65 | 30.22B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
54.91 | 9.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.68 | 6.92B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
79.45 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.73 | 6.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell upgraded at BofA on buying opportunity ahead of Q4 results - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q4 2025 Earnings Call Transcript - Insider Monkey
Analyst Jessica Tassan Lowers Omnicell (OMCL) Price Target to $4 - GuruFocus
Omnicell Q4 2025 Earnings: Stock Dives on Missed EPS, 2026 GuidanceNews and Statistics - IndexBox
Omnicell Stock Pre-Market (-15%) : Q4 EPS Miss & Weak 2026 Guidance - Trefis
Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained) - TipRanks
Pharmacy Automation Systems Market Set for Explosive Growth - openPR.com
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook - Finviz
Omnicell Stock Pre-Market (+15%): Raises FY26 Guidance on Strong Titan XT Adoption - Trefis
Omnicell Q4 Earnings Call Highlights - Yahoo Finance
Omnicell targets $1.215B–$1.255B 2026 revenue as Titan XT and OmniSphere fuel platform push - MSN
Omnicell Q4 2025 slides: EPS miss drives 15% stock drop despite revenue growth - Investing.com Nigeria
Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Dem - GuruFocus
Assessing Omnicell (OMCL) Valuation After Recent Share Price Gains And High P/E Multiple - Yahoo Finance
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results - BioSpace
Why Omnicell (OMCL) Shares Are Plunging Today - Finviz
Omnicell’s Strategic Pivot Meets Near-Term Profit Pressure - AD HOC NEWS
Omnicell (OMCL) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Omnicell Q4 2025 misses EPS forecast, shares drop - Investing.com Nigeria
Omnicell earnings: What to look for from OMCL - MSN
Omnicell's (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations - Finviz
Omnicell (OMCL) Q4 Earnings Miss, Revenue Surpasses Expectations - GuruFocus
Omnicell Q4 Non-GAAP Net Income Falls, Revenue Rises; 2026 Guidance Issued - marketscreener.com
Omnicell (OMCL) Q4 Earnings Lag Estimates - Yahoo Finance
Omnicell: Fourth Quarter Financial Highlights - Bitget
(OMCL) Omnicell, Inc. Expects Q1 Adjusted EPS Range $0.26$0.36 - marketscreener.com
Omnicell: Q4 Earnings Snapshot - Jacksonville Daily Progress
OMNICELL ($OMCL) Releases Q4 2025 Earnings - Quiver Quantitative
Omnicell stock upgraded at Bank of America (OMCL:NASDAQ) - Seeking Alpha
Omnicell stock rating upgraded by BofA Securities on Titan XT launch potential - Investing.com Canada
BofA upgrades Omnicell as new product cycle to drives revenue revisions - Investing.com Canada
Omnicell’s Drop Meets a Rare Bullish Twist - TipRanks
Understanding the Setup: (OMCL) and Scalable Risk - Stock Traders Daily
Omnicell Earnings: What To Look For From OMCL - Finviz
Omnicell, Inc. (OMCL) Stock Analysis: Investor Optimism Soars with 15.87% Potential Upside - DirectorsTalk Interviews
Support Test: How correlated is Vivani Medical Inc to the S P500Weekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
Assessing Omnicell: Insights From 5 Financial Analysts - Benzinga
Omnicell (OMCL) Analyst Rating Update: Benchmark Raises Price Ta - GuruFocus
Omnicell stock price target raised to $60 from $50 at Benchmark - Investing.com Canada
Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL) - Finviz
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Is Omnicell (NASDAQ:OMCL) A Risky Investment? - 富途牛牛
Federated Hermes Inc. Cuts Stake in Omnicell, Inc. $OMCL - MarketBeat
Omnicell Stock In Focus: Quiet Chart, Cautious Street, And A Healthcare Tech Wild Card - AD HOC NEWS
Trade Recap: What chart patterns are forming on Omnicell Inc2025 EndofYear Setup & Weekly High Return Forecasts - baoquankhu1.vn
Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline - Finviz
Omnicell (OMCL) Expected to Announce Earnings on Thursday - MarketBeat
1 Healthcare Stock to Consider Right Now and 2 We Brush Off - Barchart.com
Is Omnicell (OMCL) Fairly Priced After Recent Share Price Recovery? - Yahoo Finance
Omnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation - Sahm
Omnicell XT Amplify Puts Medication Management And Growth Story To Test - Sahm
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
1.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):